Aquestive Therapeutics, Inc. AQST Accounts Receivable, Allowance for Credit Loss, Pre-Reclassification
Accounts Receivable, Allowance for Credit Loss, Pre-Reclassification at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept aqst:AccountsReceivableAllowanceForCreditLossPreReclassification.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s accounts receivable, allowance for credit loss, pre-reclassification.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s accounts receivable, allowance for credit loss, pre-reclassification?
- Aquestive Therapeutics, Inc. (AQST) reported accounts receivable, allowance for credit loss, pre-reclassification of $0 in Q1 2026.
- What does accounts receivable, allowance for credit loss, pre-reclassification mean?
- This represents the estimated reserve established to account for potential uncollectible amounts within the company's receivables portfolio before any specific reclassifications. It serves as a buffer against credit risk and reflects management's assessment of counterparty default probability. A rising allowance may indicate deteriorating credit quality among customers or partners.